| |
| |
|
| Insider
Information: |
Edwards Larry G. |
| Relationship: |
Chief Executive Office... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tetraphase Pharmaceuticals Inc |
TTPH |
See Remarks, Director |
2020-07-28 |
0 |
2019-01-06 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Executive Office... |
2022-08-22 |
0 |
2021-04-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• • – |
2022-08-22 |
4 |
D |
$6.23 |
$74,567 |
D/D |
(11,969) |
0 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-04-14 |
4 |
A |
$3.71 |
$1,099 |
D/D |
296 |
11,969 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-03-31 |
4 |
A |
$3.63 |
$1,212 |
D/D |
334 |
11,673 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-03-15 |
4 |
A |
$3.37 |
$1,215 |
D/D |
361 |
11,339 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-02-28 |
4 |
A |
$3.48 |
$1,217 |
D/D |
350 |
10,978 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-02-15 |
4 |
A |
$3.79 |
$1,213 |
D/D |
320 |
10,628 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-01-31 |
4 |
A |
$3.94 |
$16,411 |
D/D |
4,170 |
10,308 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2022-01-14 |
4 |
A |
$4.18 |
$1,142 |
D/D |
273 |
6,138 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-12-30 |
4 |
A |
$3.92 |
$913 |
D/D |
233 |
5,865 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-12-15 |
4 |
A |
$3.58 |
$1,145 |
D/D |
320 |
5,632 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-11-15 |
4 |
A |
$3.41 |
$1,145 |
D/D |
336 |
4,966 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-10-29 |
4 |
A |
$3.42 |
$1,145 |
D/D |
335 |
4,630 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-10-15 |
4 |
A |
$3.37 |
$1,148 |
D/D |
341 |
4,295 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-09-30 |
4 |
A |
$3.39 |
$1,146 |
D/D |
338 |
3,954 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-09-15 |
4 |
A |
$3.39 |
$1,146 |
D/D |
338 |
3,616 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-08-31 |
4 |
A |
$3.58 |
$1,145 |
D/D |
320 |
3,278 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-08-13 |
4 |
A |
$3.38 |
$1,143 |
D/D |
338 |
2,958 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-07-30 |
4 |
A |
$3.07 |
$1,148 |
D/D |
374 |
2,620 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-07-15 |
4 |
A |
$3.20 |
$1,144 |
D/D |
358 |
2,246 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-06-15 |
4 |
A |
$4.17 |
$1,145 |
D/D |
275 |
1,573 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-05-28 |
4 |
A |
$3.66 |
$1,148 |
D/D |
314 |
1,298 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-05-14 |
4 |
A |
$3.20 |
$1,144 |
D/D |
358 |
984 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-04-30 |
4 |
A |
$3.77 |
$1,147 |
D/D |
304 |
626 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Executive Officer |
• – – |
2021-04-15 |
4 |
A |
$3.55 |
$1,144 |
D/D |
322 |
322 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
See Remarks |
• • – |
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,346) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
